2,4-Diamino-6-phenyl-1,3,5-triazine

Catalog No.: 
ACRSNI395
CAS No.: 
91-76-9
Molecular Formula: 
C9H9N5
Molecular Weight: 
187.21
2,4-Diamino-6-phenyl-1,3,5-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1000g95%$56.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Diamino-6-phenyl-1,3,5-triazine
IUPAC Name6-phenyl-1,3,5-triazine-2,4-diamine
MDL No.MFCD00023187
Molecular FormulaC9H9N5
Molecular Weight187.21
SMILESNC1=NC(C2=CC=CC=C2)=NC(N)=N1
InChI KeyGZVHEAJQGPRDLQ-UHFFFAOYSA-N
Synonym4,6-Diamino-2-phenyl-s-triazine | 6-Phenyl-1,3,5-triazine-2,4-diamine | Benzoguanamine | 6-Phenyl-1,3,5-triazine-2,4-diyldiamine
CAS No.91-76-9
PubChem CID7064

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H412
Precautionary Statement(s)
P264-P270-P273-P301+P312+P330-P501

Synthetic Route by SureRoute

1. ACRSNI395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRSNI395 route product structure diagram
    ACRSNI39591-76-9In Stock
Inquiry

2. ACRSNI395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMZLC347 route compound structure diagram
    ACMZLC3473397-62-4In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACRSNI395 route product structure diagram
    ACRSNI39591-76-9In Stock
Inquiry

3. ACRSNI395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACRSNI395 route product structure diagram
    ACRSNI39591-76-9In Stock
Inquiry

Comments (0)